• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles

4-Chlorobenzo[d]oxazol-2-amine: A Comprehensive Overview

4-Chlorobenzo[d]oxazol-2-amine, also known by its CAS registry number CAS No. 64037-10-1, is a heterocyclic aromatic compound that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of benzoxazole derivatives, which are widely studied for their diverse biological activities and potential applications in drug discovery.

The molecular structure of 4-Chlorobenzo[d]oxazol-2-amine consists of a benzene ring fused with an oxazole ring, where the oxazole moiety contains an oxygen atom and a nitrogen atom at positions 1 and 3, respectively. The chlorine substituent at position 4 of the benzene ring introduces electronic effects that can significantly influence the compound's reactivity and biological properties. This substitution pattern also enhances the compound's stability and solubility, making it a valuable substrate for further chemical modifications.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 4-Chlorobenzo[d]oxazol-2-amine through various methodologies, including oxidative coupling reactions and cyclization processes. These methods not only improve the yield but also allow for precise control over the substitution patterns, which is critical for optimizing biological activity.

In terms of physical properties, 4-Chlorobenzo[d]oxazol-2-amine exhibits a melting point of approximately 235°C, indicating its thermal stability under standard conditions. The compound is sparingly soluble in water but shows enhanced solubility in organic solvents such as dichloromethane and ethanol, which facilitates its use in various chemical reactions and biological assays.

The biological activity of 4-Chlorobenzo[d]oxazol-2-amine has been extensively investigated in recent years. Studies have demonstrated that this compound possesses potent antioxidant properties, making it a promising candidate for applications in oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases. Additionally, research has shown that 4-Chlorobenzo[d]oxazol-2-amine exhibits moderate anti-inflammatory activity, which could be exploited for the development of novel anti-inflammatory agents.

A recent study published in the Journal of Medicinal Chemistry highlighted the potential of 4-Chlorobenzo[d]oxazol-2-amine as a lead compound for anticancer drug development. The compound was found to induce apoptosis in various cancer cell lines by modulating key signaling pathways involved in cell proliferation and survival. These findings underscore the importance of further exploring the pharmacological profile of this compound to unlock its full therapeutic potential.

In conclusion, 4-Chlorobenzo[d]oxazol-2-amime, with its unique chemical structure and promising biological properties, represents a valuable addition to the arsenal of heterocyclic compounds used in drug discovery. Ongoing research continues to unravel its potential applications, positioning it as a key player in the development of novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)